Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians

Clinical and Vaccine Immunology

Volumn 17, Issue 9, 2010, Pages 1473-1477

  Benmansour, Jihen ^a   Stayoussef, Mouna ^a   Al Jenaidi, Fayza A ^b,c   Rajab, Mansoor H ^b   Rayana, Chiheb B ^d   Said, Hichem B ^e   Mahjoub, Touhami ^a   Almawi, Wassim Y ^c  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b Salmaniya Medical Complex ^*  (Bahrain)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

^d Institut National de Nutrition Tunis   (Tunisia)

^e FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ALLELE; ARAB; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ANTIGENS, CD; CHILD; DIABETES MELLITUS, TYPE 1; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; HAPLOTYPES; HOMOZYGOTE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TUNISIA; YOUNG ADULT;

EID: 77956420229     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00099-10     Document Type: Article

References (35)

1. Al-Jenaidi, F. A., S. F. Wakim-Ghorayeb, A. Al-Abbasi, M. R. Arekat, N. Irani-Hakime, P. Najm, K. Al-Ola, A. A. Motala, and W. Y. Almawi. 2005. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. J. Clin. Endocrinol. Metab. 90:5104-5109.
2. Almasi, S., N. Erfani, Z. Mojtahedi, A. Rajaee, and A. Ghaderi. 2006. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population. Genes Immun. 7:401-406. (Pubitemid 44111645)
3. Atkinson, M. A., and G. S. Eisenbarth. 2001. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229.
4. Balbi, G., F. Ferrera, M. Rizzi, P. Piccioli, A. Morabito, L. Cardamone, M. Ghio, G. L. Palmisano, P. Carrara, S. Pedemonte, M. Sessarego, M. De Angioletti, R. Notaro, F. Indiveri, and M. P. Pistillo. 2007. Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clin. Exp. Immunol. 149:40-47.
5. Balic, I., B. Angel, E. Codner, E. Carrasco, and F. Pérez-Bravo. 2009. Association of CTLA-4 polymorphisms and clinical-immunologic characteris- tics at onset of type 1 diabetes mellitus in children. Hum. Immunol. 70:116-120.
6. Baniasadi, V., N. Narain, R. Goswami, and S. N. Das. 2006. Promoter region -318 C/T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 67:383-389.
7. Bottini, N., L. Musumeci, A. Alonso, S. Rahmouni, K. Nika, M. Rostamkhani, J. MacMurray, G. F. Meloni, P. Lucarelli, M. Pellecchia, G. S. Eisenbarth, D. Comings, and T. Mustelin. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat. Genet. 36:337-338.
8. Caputo, M., G. E. Cerrone, C. Mazza, N. Cédola, H. M. Targovnik, and D. F. Gustavo. 2007. No evidence of association of CTLA-4 -318 C/T, 159 C/T, 3′ STR and SUMO4 163 AG polymorphism with autoimmune diabetes. Immunol. Invest. 36:259-270.
9. Carreno, B. M., F. Bennett, T. A. Chau, V. Ling, D. Luxenberg, J. Jussif, M. L. Baroja, and J. Madrenas. 2000. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J. Immunol. 165:1352-1356.
10. Concannon, P., W. M. Chen, C. Julier, G. Morahan, B. Akolkar, H. A. Erlich, J. E. Hilner, J. Nerup, C. Nierras, F. Pociot, J. A. Todd, S. S. Rich, and the Type 1 Diabetes Genetics Consortium. 2009. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 58:1018-1022.
11. Cox, N. J., B. Wapelhorst, V. A. Morrison, L. Johnson, L. Pinchuk, R. S. Spielman, J. A. Todd, and P. Concannon. 2001. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 7657 multiplex families. Am. J. Hum. Genet. 69:820-830.
12. Davies, J. L., Y. Kawaguchi, S. T. Bennett, J. B. Copeman, H. J. Cordell, L. E. Pritchard, P. W. Reed, S. C. Gough, S. C. Jenkins, and S. M. Palmer. 1994. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136.
13. Donaghue, K. C., F. Chiarelli, D. Trotta, J. Allgrove, and K. Dahl-Jorgensen. 2009. Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr. Diabetes 10(Suppl. 12):195-203.
14. Douroudis, K., A. P. Laine, M. Heinonen, R. Hermann, K. Lipponen, R. Veijola, O. Simell, M. Knip, R. Uibo, J. Ilonen, and K. Kisand. 2009. Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. Hum. Immunol. 70:536-539.
15. Hunt, K. A., D. P. McGovern, P. J. Kumar, S. Ghosh, S. P. Travis, J. R. Walters, D. P. Jewell, R. J. Playford, and D. A. van Heel. 2005. A common CTLA4 haplotype associated with coeliac disease. Eur. J. Hum. Genet. 13:440-444.
16. Ikegami, H., T. Awata, E. Kawasaki, T. Kobayashi, T. Maruyama, K. Nakanishi, A. Shimada, S. Amemiya, Y. Kawabata, S. Kurihara, S. Tanaka, Y. Kanazawa, M. Mochizuki, and T. Ogihara. 2006. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J. Clin. Endocrinol. Metab. 91:1087-1092.
17. Jin, P., B. Xiang, J. Lin, G. Huang, W. D. Zhou, C. Zheng, C. Chao, and Z. G. Zhou. 2009. Association of CTLA-4 + 49A/G and CT60 gene polymorphism with type 1 diabetes and thyroid autoimmunity. Zhonghua Yi Xue Za Zhi 89:1246-1249.
18. Julier, C., R. N. Hyer, J. Davies, F. Merlin, P. Soularue, L. Briant, G. Cathelineau, I. Deschamps, J. I. Rotter, and P. Froguel. 1991. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 354:155-159.
19. Jung, M. H., J. Yu, C. H. Shin, B. K. Suh, S. W. Yang, and B. C. Lee. 2009. Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms and HLA class II alleles with the development of type 1 diabetes in Korean children and adolescents. J. Korean Med. Sci. 24:1004-1009.
20. Kavvoura, F. K., and J. P. Ioannidis. 2005. CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis. Am. J. Epidemiol. 162:3-16.
21. Kosmaczewska, A., L. Ciszak, D. Boćko, and I. Frydecka. 2001. Expression and functional significance of CTLA-4, a negative regulator of T cell activation. Arch. Immunol. Ther. Exp. 49:39-46.
22. Lemos, M. C., E. Coutinho, L. Gomes, M. Bastos, A. Fagulha, L. Barros, F. Carrilho, E. Geraldes, F. J. Regateiro, and M. Carvalheiro. 2009. The CTLA4 +49 A/G polymorphism is not associated with susceptibility to type 1 diabetes mellitus in the Portuguese population. Int. J. Immunogenet. 36:193-195.
23. Marron, M. P., L. J. Raffel, H. J. Garchon, C. O. Jacob, M. Serrano-Rios, M. T. Martinez Larrad, W. P. Teng, Y. Park, Z. X. Zhang, D. R. Goldstein, Y. W. Tao, et al. 1997. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet. 6:1275-1282.
24. Mayans, S., K. Lackovic, C. Nyholm, P. Lindgren, K. Ruikka, M. Eliasson, C. M. Cilio, and D. Holmberg. 2007. CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Med. Genet. 8:3.
25. Nisticò, L., R. Buzzetti, L. E. Pritchard, B. van der Auwera, C. Giovannini, E. Bosi, M. T. Larrad, M. S. Rios, C. C. Chow, C. S. Cockram, K. Jacobs, C. Mijovic, S. C. Bain, A. H. Barnett, C. L. Vandewalle, F. Schuit, F. K. Gorus, R. Tosi, P. Pozzilli, and J. A. Todd. 1996. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum. Mol. Genet. 5:1075-1080.
26. Pugliese, A., and D. Miceli. 2002. The insulin gene in diabetes. Diabetes Metab. Res. Rev. 18:13-25.
27. Qu, H. Q., J. P. Bradfield, S. F. Grant, H. Hakonarson, C. Polychronakos, and the Type I Diabetes Genetics Consortium. 2009. Remapping the type I diabetes association of the CTLA4 locus. Genes Immun. 10(Suppl. 1):S27-S32.
28. Stayoussef, M., J. Benmansour, A. Q. Al-Irhayim, H. B. Said, C. B. Rayana, T. Mahjoub, and W. Y. Almawi. 2009. Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia. Clin. Vaccine Immunol. 16:1146-1150.
29. Todd, J. A., N. M. Walker, J. D. Cooper, D. J. Smyth, K. Downes, V. Plagnol, R. Bailey, S. Nejentsev, S. F. Field, F. Payne, C. E. Lowe, J. S. Szeszko, J. P. Hafler, L. Zeitels, J. H. Yang, A. Vella, S. Nutland, H. E. Stevens, H. Schuilenburg, G. Coleman, M. Maisuria, et al. 2007. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39:857-864.
30. Turpeinen, H., A. P. Laine, R. Hermann, O. Simell, R. Veijola, M. Knip, and J. Ilonen. 2003. A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes. Eur. J. Immunogenet. 30:289-293.
31. Ueda, H., J. M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D. B. Rainbow, K. M. Hunter, A. N. Smith, G. Di Genova, M. H. Herr, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-551.
32. Vaidya, B., and S. Pearce. 2004. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. Eur. J. Endocrinol. 150:619-626.
33. Wells, A. D., M. C. Walsh, J. A. Bluestone, and L. A. Turka. 2001. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J. Clin. Invest. 108:895-903.
34. Zalloua, P. A., A. Abchee, H. Shbaklo, T. G. Zreik, H. Terwedow, G. Halaby, and S. T. Azar. 2004. Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. Hum. Immunol. 65:719-724.
35. Zhernakova, A., P. Eerligh, P. Barrera, J. Z. Wesoly, T. W. Huizinga, B. O. Roep, C. Wijmenga, and B. P. Koeleman. 2005. CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum. Genet. 118:58-66.